MHC antigen expression in human oral squamous carcinoma cell lines
- PMID: 1744799
- DOI: 10.1002/path.1711650208
MHC antigen expression in human oral squamous carcinoma cell lines
Abstract
This study quantified the constitutive and interferon-gamma (IFN-gamma) stimulated expression of MHC class I (HLA-ABC and beta 2 microglobulin) and class II antigens (HLA-DR, -DP, -DQ) on normal and malignant oral keratinocytes using radioimmunoassay and immunocytochemical techniques. Normal keratinocytes and three of four malignant cell lines (H103, H157, H314) expressed MHC class I antigens constitutively; IFN-gamma increased MHC class I expression with significant changes in normals, H157 and H314. Normal keratinocytes expressed significantly more constitutive MHC class I antigens than H103 and H157 and significantly more IFN-gamma stimulated MHC class I antigens than H103, H157 and H314. MHC class II antigens predominantly were not expressed constitutively on normals, H103 and H157 but, in H314, HLA-DR, -DP and -DQ antigens were demonstrated on 35, 11 and 5 per cent of cells, respectively, and resulted in a non-coordinated pattern of expression (HLA-DR greater than -DP = -DQ). IFN-gamma induced HLA-DR on normals, H103 and H157, whilst HLA-DP and -DQ remained undetectable. In H314, IFN-gamma enhanced HLA-DR, -DP and -DQ (significant increase of HLA-DQ) but the interrelationship between these antigens was maintained (HLA-DR greater than -DP = -DQ). Normal keratinocytes expressed significantly more IFN-gamma stimulated HLA-DR than H103 and H157 but significantly less HLA-DR than H314 under similar experimental conditions. One oral malignant cell line (H191) did not express MHC class I and MHC class II antigens either constitutively or in response to IFN-gamma. The results demonstrate aberrant patterns of MHC expression (absence, enhanced, diminished) in the different malignant oral keratinocyte cell lines.
Similar articles
-
HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta.J Natl Cancer Inst. 1985 Jun;74(6):1261-8. J Natl Cancer Inst. 1985. PMID: 3923246
-
Expression and function of class II antigens on gastric carcinoma cells and gastric epithelia: differential expression of DR, DQ, and DP antigens.J Natl Cancer Inst. 1987 Nov;79(5):923-32. J Natl Cancer Inst. 1987. PMID: 2960847
-
Induction of MHC class II molecules HLA-DR, -DP and -DQ and ICAM 1 in human podocytes by gamma-interferon.Exp Nephrol. 1994 Sep-Oct;2(5):306-12. Exp Nephrol. 1994. PMID: 7812737
-
Expression of MHC class II antigens in human B-cell leukaemia and non-Hodgkin's lymphoma.Br J Cancer. 1986 Feb;53(2):161-73. doi: 10.1038/bjc.1986.31. Br J Cancer. 1986. PMID: 3513812 Free PMC article. Review.
-
Current research status of HLA in immune-related diseases.Immun Inflamm Dis. 2021 Jun;9(2):340-350. doi: 10.1002/iid3.416. Epub 2021 Mar 3. Immun Inflamm Dis. 2021. PMID: 33657268 Free PMC article. Review.
Cited by
-
Immune Tolerance in the Oral Mucosa.Int J Mol Sci. 2021 Nov 10;22(22):12149. doi: 10.3390/ijms222212149. Int J Mol Sci. 2021. PMID: 34830032 Free PMC article. Review.
-
StrataGraft skin substitute is well-tolerated and is not acutely immunogenic in patients with traumatic wounds: results from a prospective, randomized, controlled dose escalation trial.Ann Surg. 2011 Apr;253(4):672-83. doi: 10.1097/SLA.0b013e318210f3bd. Ann Surg. 2011. PMID: 21475006 Free PMC article. Clinical Trial.
-
SHP2 negatively regulates HLA-ABC and PD-L1 expression via STAT1 phosphorylation in prostate cancer cells.Oncotarget. 2017 Jun 21;8(32):53518-53530. doi: 10.18632/oncotarget.18591. eCollection 2017 Aug 8. Oncotarget. 2017. PMID: 28881828 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials